NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Spectrum Pharmaceuticals Inc (NASDAQ: SPPI)

 
SPPI Technical Analysis
3
As on 9th Jun 2023 SPPI STOCK Price closed @ 1.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.87 & Buy for SHORT-TERM with Stoploss of 0.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SPPISTOCK Price

Open 1.03 Change Price %
High 1.05 1 Day -0.03 -2.86
Low 1.01 1 Week -0.05 -4.67
Close 1.02 1 Month 0.10 10.87
Volume 964800 1 Year -0.48 -32.00
52 Week High 1.59 | 52 Week Low 0.32
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
SPPI
Daily Charts
SPPI
Intraday Charts
Whats New @
Bazaartrend
SPPI
Free Analysis
 
SPPI Important Levels Intraday
RESISTANCE1.10
RESISTANCE1.07
RESISTANCE1.06
RESISTANCE1.04
SUPPORT1.00
SUPPORT0.98
SUPPORT0.97
SUPPORT0.94
 
SPPI Forecast May 2024
4th UP Forecast2.29
3rd UP Forecast1.88
2nd UP Forecast1.63
1st UP Forecast1.38
1st DOWN Forecast0.66
2nd DOWN Forecast0.41
3rd DOWN Forecast0.16
4th DOWN Forecast-0.25
 
SPPI Weekly Forecast
4th UP Forecast1.77
3rd UP Forecast1.53
2nd UP Forecast1.38
1st UP Forecast1.23
1st DOWN Forecast0.81
2nd DOWN Forecast0.66
3rd DOWN Forecast0.51
4th DOWN Forecast0.27
 
SPPI Forecast2024
4th UP Forecast3.53
3rd UP Forecast2.72
2nd UP Forecast2.23
1st UP Forecast1.73
1st DOWN Forecast0.31
2nd DOWN Forecast-0.19
3rd DOWN Forecast-0.68
4th DOWN Forecast-1.49
 
 
SPPI Other Details
Segment EQ
Market Capital 318299680.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SPPI Address
SPPI
 
SPPI Latest News
 
Your Comments and Response on Spectrum Pharmaceuticals Inc
 
SPPI Business Profile
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada. Address: 11500 South Eastern Avenue, Henderson, NV, United States, 89052
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service